Currently, Edward H. Myles occupies the position of Chief Financial Officer & Head-Business Operations at Scholar Rock Holding Corp. and Chief Financial Officer & Head-Business Operations at Scholar Rock, Inc. (a subsidiary of Scholar Rock Holding Corp.) and Chief Financial Officer, Treasurer & Director at AMAG Pharma USA, Inc. Mr. Myles is also Treasurer & Director at School On Wheels of Massachusetts.
He previously held the position of Chief Financial Officer & SVP-Finance at Pressure BioSciences, Inc., Principal at Merck KGaA and Controller at EMD Pharmaceuticals, Inc. (a subsidiary of Merck KGaA), Chief Operating & Financial Officer of Astellas Institute for Regenerative Medicine, Chief Financial Officer & VP-Operations at PrimeraDx, Inc., COO, Chief Financial Officer, Treasurer & EVP at AMAG Pharmaceuticals, Inc., Senior Associate at PricewaterhouseCoopers LLP, Associate-Healthcare Investment Banking Group at SG Cowen Securities Corp. and Controller for Boston Biomedical, Inc.
Edward H. Myles received an undergraduate degree from the University of Hartford and an MBA from Olin Business School.
What is Edward H. Myles' net worth?
The estimated net worth of Edward H. Myles is at least $5.18 million as of March 10th, 2025. Mr. Myles owns 111,345 shares of Scholar Rock stock worth more than $5,175,316 as of May 5th. This net worth estimate does not reflect any other investments that Mr. Myles may own. Learn More about Edward H. Myles' net worth.
How do I contact Edward H. Myles?
Has Edward H. Myles been buying or selling shares of Scholar Rock?
Edward H. Myles has not been actively trading shares of Scholar Rock over the course of the past ninety days. Most recently, Edward H. Myles sold 142,292 shares of the business's stock in a transaction on Monday, March 10th. The shares were sold at an average price of $35.62, for a transaction totalling $5,068,441.04. Following the completion of the sale, the chief financial officer now directly owns 111,345 shares of the company's stock, valued at $3,966,108.90. Learn More on Edward H. Myles' trading history.
Who are Scholar Rock's active insiders?
Scholar Rock's insider roster includes Srinivas Akkaraju (Director), Jay Backstrom (President & CEO), Kristina Burow (Director), Jeffrey Flier (Director), Michael Gilman (Director), David Hallal (CEO), Junlin Ho (General Counsel & Corporate Secretary), Jing Marantz (Chief Medical Officer), Edward Myles (CFO), Caryn Parlavecchio (Insider), Katie Peng (Chief Commercial Officer, Denali Therapeutics), Mo Qatanani (Insider), Joshua Reed (Director), Tracey Sacco (Chief Commercial Officer), Vikas Sinha (CFO), Akshay Vaishnaw (President, R&D), Keith Woods (COO), and Keith Woods (COO). Learn More on Scholar Rock's active insiders.
Are insiders buying or selling shares of Scholar Rock?
In the last year, Scholar Rock insiders bought shares 3 times. They purchased a total of 530,038 shares worth more than $19,988,928.11. In the last year, insiders at the sold shares 33 times. They sold a total of 509,614 shares worth more than $21,862,372.68. The most recent insider tranaction occured on April, 16th when COO Keith Woods sold 10,220 shares worth more than $506,605.40. Insiders at Scholar Rock own 13.3% of the company.
Learn More about insider trades at Scholar Rock. Information on this page was last updated on 4/16/2026.
